Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML.
Leuk Res. 2024 May;140:107497. doi: 10.1016/j.leukres.2024.107497. Epub 2024 Mar 27.
Leuk Res. 2024.
PMID: 38564986
Free article.
Clinical Trial.
Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trials.
Montesinos P, Fathi AT, de Botton S, Stein EM, Zeidan AM, Zhu Y, Prebet T, Vigil CE, Bluemmert I, Yu X, DiNardo CD.
Montesinos P, et al. Among authors: bluemmert i.
Blood Adv. 2024 May 28;8(10):2509-2519. doi: 10.1182/bloodadvances.2023011914.
Blood Adv. 2024.
PMID: 38507688
Free PMC article.
Item in Clipboard
Cite
Cite